Probability of OncotypeDx to Reallocate as Low or High Risk of Recurrence Breast Cancer Patients With Uncertain Biology
Conditions: Breast Cancer Sponsors: Fondazione Sandro Pitigliani; Genomic Health ®, Inc.; Istituto Toscano Tumori Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Neural Changes Following Cognitive Behavior Therapy for Procrastination
Conditions: Procrastination Interventions: Behavioral: Psychoeducation and cognitive modules; Behavioral: Behavioral module: Starting on Time and Planning Realistically; Behavioral: Behavioral module: Working Time Restriction Sponsors: Nencki Institute of Experimental Biology of the Polish Academy of Sciences; SWPS University of Social Sciences and Humanities; Institute of Psychology, Polish Academy of Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Screen-and-treat Strategy for Vaginal Flora Abnormalities in Pregnant Women at High Risk of Preterm Birth
Conditions: Bacterial Vaginosis; Vaginal Dysbiosis; Premature Delivery Interventions: Diagnostic Test: Vaginal flora abnormalities screening and quantification using molecular biology technique; Drug: Azithromycine; Drug: Ceftriaxone; Drug: Metronidazole; Drug: Clotrimazole, Vaginal; Other: Usual Care Sponsors: Assistance Publique Hopitaux De Marseille Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Filling Key Research Gaps With Clinical Implications in Mansonellosis and Schistosomiasis: a Network Approach
Conditions: Schistosoma Mansoni Interventions: Diagnostic Test: Molecular biology analyses Sponsors: IRCCS Sacro Cuore Don Calabria di Negrar Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials
Behavior, Biology and Well-Being Study
Conditions: Depression; Psychological Distress Interventions: Device: Healthy Minds Program; Other: Psychoeducation app Sponsors: University of Wisconsin, Madison; Hope for Depression Research Foundation; National Center for Complementary and Integrative Health (NCCIH) Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2024 Category: Research Source Type: clinical trials
Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine
Conditions: Hand, Foot and Mouth Disease Interventions: Biological: Enterovirus Type 71 Vaccine, inactivated ( Human Diploid Cell ); Biological: Recombinant Hepatitis B Vaccine; Biological: Group A meningococcal polysaccharide vaccine Sponsors: Jiangsu Province Centers for Disease Control and Prevention; Institute of Medical Biology, Chinese Academy of Medical Sciences Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
Conditions: Diphtheria; Tetanus; Pertussis Interventions: Biological: DTacP (one-dose booster); Biological: DTacP (three-dose primary vaccination); Biological: DT (one-dose booster); Biological: DTaP (one-dose booster); Biological: PENTAXIM (one-dose booster); Biological: DTaP (three-dose primary vaccination); Biological: PENTAXIM (three-dose primary vaccination) Sponsors: Institute of Medical Biology, Chinese Academy of Medical Sciences; Sichuan Center for Disease Control and Prevention Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
Vesper Bio doses first volunteer in Phase I study of first-in-class oral treatment for Frontotemporal Dementia
COPENHAGEN, Denmark, Dec. 7, 2023. Vesper Bio ApS ( " Vesper " or " the Company " ), a clinical stage biotech and world leader in sortilin receptor biology, today announces that the first volunteer has been dosed with its lead compound VES001, a patient... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 7, 2023 Category: Pharmaceuticals Source Type: clinical trials
Antibiotics and Vaccine Immune Responses Study
Conditions: Vaccine Response Impaired Interventions: Biological: BCG vaccine; Biological: Yellow Fever vaccine; Drug: Vancomycin Oral Capsule; Drug: Neomycin Oral Product Sponsors: South Australian Health and Medical Research Institute; Royal Adelaide Hospital; Flinders University; University of Sydney; Telethon Kids Institute; Centenary Institute of Cancer Medicine and Cell Biology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria
Conditions: Vivax Malaria Interventions: Drug: Tafenoquine; Drug: Primaquin Sponsors: Menzies School of Health Research; University of Melbourne; Funda ção de Medicina Tropical Dr. Heitor Vieira Dourado; Arba Minch University; Addis Ababa University; Papuan Community Health and Development Foundation, Indonesia; Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Indonesia; Curtin University; Papua New Guinea I nstitute of Medical Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 28, 2023 Category: Research Source Type: clinical trials
Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 Vaccine
Conditions: Hand, Foot and Mouth Disease Interventions: Biological: EV71 Vaccine Sponsors: Institute of Medical Biology, Chinese Academy of Medical Sciences; Shanxi Center for Disease Control and Prevention Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials
Monkeypox, Biology, Outcome, Transmission and Epidemiology -Prospective Follow-up of High-risk Contacts
Conditions: Mpox Sponsors: Institute of Tropical Medicine, Belgium; Institut National de Recherche Biom édicale. Kinshasa, République Démocratique du Congo; National Institute of Allergy and Infectious Diseases (NIAID); Leidos Biomedical Research, Inc.; Alliance for International Medical Action; University of California, Los Angeles; Institut de Recherche pour le Developpement; University of Manito ba Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
A large international study of migraine reveals new biological pathways for treatment
REYKJAVIK, Iceland , Oct. 26, 2023. A large international study led by deCODE Genetics on the genetics of migraine provides novel insights into the biology of migraine enabling detection of rare variants protecting against migraine, opening an... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 26, 2023 Category: Pharmaceuticals Source Type: clinical trials
Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002
Conditions: Hair Diseases; Alopecia; Hair Loss Interventions: Combination Product: DA-OTC-002 Sponsors: Applied Biology, Inc. Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
Conditions: Glioblastoma; Recurrent Glioblastoma; Resectable Glioblastoma Interventions: Procedure: Biospecimen Collection; Procedure: Magnetic Resonance Imaging; Other: Medical Chart Review Sponsors: Jonsson Comprehensive Cancer Center; National Cancer Institute (NCI) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2023 Category: Research Source Type: clinical trials
